comparemela.com
Home
Live Updates
O Fulc Us3596161097 - Breaking News
Pages:
Latest Breaking News On - O fulc us3596161097 - Page 1 : comparemela.com
Fulcrum Therapeutics® Announces Additional HBG mRNA Induction from Higher Dose Cohorts in Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease and New Preclinical Mechanism Data
Achieved mean 5.6-fold HBG mRNA induction at 20mg and mean 6.2-fold at 30mg after 14 days of once-daily dosing, further supporting potential of FTX-6058 to provide a functional cure Continues to be. | December 6, 2021
United kingdom
United states
Kaitlin gallagher
Franke weise
Bryan stuart
Stephanie ascher
Naomi aoki
Christi waarich
Gerd blobel
Stern investor relations inc
Drug administration
Embryonic ectoderm development
Replay international number
Exchange commission
International number
Fulcrum therapeutics inc
vimarsana © 2020. All Rights Reserved.